About us

Client relationships based on trust and openness are an essential working principle of Lampe & Company.

Our clients

Client relationships based on trust and openness are an essential working principle of Lampe & Company.

Due to the sensitive nature of much of the information we exchange with our clients, we deliberately refrain from stating the names of corporations here. On request, we are glad to mediate the direct contact to our clients’ contact partners.

20

Top 20 companies from the pharmaceutical, medtech and biotech fields, as well as startups and biotechnology investors

Represented in all the main disease areas, including oncology, cardiovascular and metabolic diseases, infections, autoimmune diseases and CNS disorders, as well as orphan indications

Spread across the globe:
America, Europe, Asia, Australia

4Billion US$

Transaction volume of supported start-up companies amounting to > 4 billion US$

Our clients

Client relationships based on trust and openness are an essential working principle of Lampe & Company.

Due to the sensitive nature of much of the information we exchange with our clients, we deliberately refrain from stating the names of corporations here. On request, we are glad to mediate the direct contact to our clients’ contact partners.

Our values

COST-EFFECTIVE RESULTS

We deliver the right results to each client, as cost-effectively as possible.

FACT-BASED ARGUMENTS

We provide data reports that are unbiased, objective, and quantitative.

ACTING WITH INTEGRITY

We build relationships based on mutual trust.

HIGHEST SCIENTIFIC COMPETENCE

Our team consists of data analysts with profound medical and life sciences background

Management

Portrait PD Dr. Johannes Lampe

PD Dr. Johannes Lampe

CEO

  • Founder (2007) and sole owner of L&C
  • Medical doctor of Virology, Neurologist
  • Profound experience in Pharma R&D
  • Strong basic research background
  • More than 20 years of operational and strategic experience, from single study to portfolio level
  • Medical, scientific and managerial responsibility for drug development programs across the R&D process
Portrait Dr. Claudia Behrens

Dr. Claudia Behrens

COO

  • Joined Lampe & Company in 2008
  • PhD in Molecular Virology
  • Master’s degree in Biotechnology
  • Broad scientific track record
  • Broad experience in all main disease areas (incl. oncology, cardiovascular and metabolic diseases, infections, autoimmune and CNS disorders)
  • Expertise from numerous preclinical and clinical projects

Reasons to believe

Founded in Berlin in 2007, Lampe & Company has many years of accumulated experience.

Our team of experts combines industry expertise with the unique L-Matrix methodology and exclusive relational L&C database to provide critical information to leading decision makers in pharmaceutical and medical device companies.

We support and facilitate operational and strategic decisions in all phases of the R&D process, from single studies to portfolio level.

Our clients value the high degree of transparency and traceability of the L&C approach, achieved through clear evaluation criteria and the documented reference to each individual data point.

Based on more than 13 years of experience in the standardization and structuring of scientific information, we perform manual data entry and analysis.
Only this approach enables the acquisition of all relevant data from a scientific publication. Not least in its level of detail, this approach is unique worldwide.

The unique way of presenting scientific data, which allows an immediate switch between scientific detail from a publication and an overview of the relevant aspects. In a Smart Report, the data is prepared/aggregated in such a way that it is immediately accessible for a decision.

Based on all relevant data from the scientific literature, selected by scientists and digitally processed with common sense.